OCCUPATIONAL HEALTH RISKS FOR MEXICAN WOMEN: THE CASE OF THE MAQUILADORA ALONG THE MEXICAN-UNITED STATES BORDER by Hovell, Melbourne F., Sipan, Carol, Hofstetter, C. Richard, DuBois, Barbara C., Krefft, Andrew, Conway, John, Jasis, Monica, Isaacs, Hope L.

Get full text

HEALTH EDUCATION IN THE BORDER CORRIDOR by Isaacs, Hope L.

Get full text

Iroquois Herbalism: the Past 100 Years by Isaacs, Hope L.

Get full text

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial by Pusztai, Lajos, Yau, Christina, Wolf, Denise M., Han, Hyo S., Du, Lili, Wallace, Anne M., String-Reasor, Erica, Boughey, Judy C., Chien, A. Jo, Elias, Anthony D., Beckwith, Heather, Nanda, Rita, Albain, Kathy S., Clark, Amy S., Kemmer, Kathleen, Kalinsky, Kevin, Isaacs, Claudine, Thomas, Alexandra, Shatsky, Rebecca, Helsten, Theresa L., Forero-Torres, Andres, Liu, Minetta C., Brown-Swigart, Lamorna, Petricoin, Emmanuel F., Wulfkuhle, Julia D., Asare, Smita M., Wilson, Amy, Singhrao, Ruby, Sit, Laura, Hirst, Gillian L., Berry, Scott, Sanil, Ashish, Asare, Adam L., Matthews, Jeffrey B., Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Yee, Doug, van’t Veer, Laura J., Hylton, Nola M., DeMichele, Angela M., Berry, Donald A., Esserman, Laura J.

Get full text

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies by Wolf, Denise M., Yau, Christina, Wulfkuhle, Julia, Brown-Swigart, Lamorna, Gallagher, Rosa I., Lee, Pei Rong Evelyn, Zhu, Zelos, Magbanua, Mark J., Sayaman, Rosalyn, O’Grady, Nicholas, Basu, Amrita, Delson, Amy, Coppé, Jean Philippe, Lu, Ruixiao, Braun, Jerome, Asare, Smita M., Sit, Laura, Matthews, Jeffrey B., Perlmutter, Jane, Hylton, Nola, Liu, Minetta C., Pohlmann, Paula, Symmans, W. Fraser, Rugo, Hope S., Isaacs, Claudine, DeMichele, Angela M., Yee, Douglas, Berry, Donald A., Pusztai, Lajos, Petricoin, Emanuel F., Hirst, Gillian L., Esserman, Laura J., van 't Veer, Laura J.

Get full text

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy by Magbanua, Mark Jesus M., Brown Swigart, Lamorna, Ahmed, Ziad, Sayaman, Rosalyn W., Renner, Derrick, Kalashnikova, Ekaterina, Hirst, Gillian L., Yau, Christina, Wolf, Denise M., Li, Wen, Delson, Amy L., Asare, Smita, Liu, Minetta C., Albain, Kathy, Chien, A. Jo, Forero-Torres, Andres, Isaacs, Claudine, Nanda, Rita, Tripathy, Debu, Rodriguez, Angel, Sethi, Himanshu, Aleshin, Alexey, Rabinowitz, Matthew, Perlmutter, Jane, Symmans, W. Fraser, Yee, Douglas, Hylton, Nola M., Esserman, Laura J., DeMichele, Angela M., Rugo, Hope S., van ’t Veer, Laura J.

Get full text

Standards of Care in Diabetes-2023 Abridged for Primary Care Providers

Get full text

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial by Clark, Amy S., Yau, Christina, Wolf, Denise M., Petricoin, Emanuel F., van ‘t Veer, Laura J., Yee, Douglas, Moulder, Stacy L., Wallace, Anne M., Chien, A. Jo, Isaacs, Claudine, Boughey, Judy C., Albain, Kathy S., Kemmer, Kathleen, Haley, Barbara B., Han, Hyo S., Forero-Torres, Andres, Elias, Anthony, Lang, Julie E., Ellis, Erin D., Yung, Rachel, Tripathy, Debu, Nanda, Rita, Wulfkuhle, Julia D., Brown-Swigart, Lamorna, Gallagher, Rosa I., Helsten, Teresa, Roesch, Erin, Ewing, Cheryl A., Alvarado, Michael, Crane, Erin P., Buxton, Meredith, Clennell, Julia L., Paoloni, Melissa, Asare, Smita M., Wilson, Amy, Hirst, Gillian L., Singhrao, Ruby, Steeg, Katherine, Asare, Adam, Matthews, Jeffrey B., Berry, Scott, Sanil, Ashish, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Hylton, Nola M., Berry, Donald A., Esserman, Laura J., DeMichele, Angela M.

Get full text

Standards of Medical Care in Diabetes-2021 Abridged for Primary Care Providers

Get full text

A Combined Genomewide Linkage Scan of 1,233 Families for Prostate Cancer–Susceptibility Genes Conducted by the International Consortium for Prostate Cancer Genetics by Xu, Jianfeng, Dimitrov, Latchezar, Chang, Bao-Li, Adams, Tamara S., Turner, Aubrey R., Meyers, Deborah A., Eeles, Rosalind A., Easton, Douglas F., Foulkes, William D., Simard, Jacques, Giles, Graham G., Hopper, John L., Mahle, Lovise, Moller, Pal, Bishop, Tim, Evans, Chris, Edwards, Steve, Meitz, Julia, Bullock, Sarah, Hope, Questa, Hsieh, Chih-lin, Halpern, Jerry, Balise, Raymond N., Oakley-Girvan, Ingrid, Whittemore, Alice S., Ewing, Charles M., Gielzak, Marta, Isaacs, Sarah D., Walsh, Patrick C., Wiley, Kathleen E., Isaacs, William B., Thibodeau, Stephen N., McDonnell, Shannon K., Cunningham, Julie M., Zarfas, Katherine E., Hebbring, Scott, Schaid, Daniel J., Friedrichsen, Danielle M., Deutsch, Kerry, Kolb, Suzanne, Badzioch, Michael, Jarvik, Gail P., Janer, Marta, Hood, Leroy, Ostrander, Elaine A., Stanford, Janet L., Lange, Ethan M., Beebe-Dimmer, Jennifer L., Mohai, Caroline E., Cooney, Kathleen A., Ikonen, Tarja, Baffoe-Bonnie, Agnes, Fredriksson, Henna, Matikainen, Mika P., Tammela, Teuvo LJ, Bailey-Wilson, Joan, Schleutker, Johanna, Maier, Christiane, Herkommer, Kathleen, Hoegel, Josef J., Vogel, Walther, Paiss, Thomas, Wiklund, Fredrik, Emanuelsson, Monica, Stenman, Elisabeth, Jonsson, Björn-Anders, Grönberg, Henrik, Camp, Nicola J., Farnham, James, Cannon-Albright, Lisa A., Seminara, Daniela

Get full text

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer by Rugo, Hope S, Campbell, Mike, Yau, Christina, Jo Chien, A, Wallace, Anne M, Isaacs, Claudine, Boughey, Judy C, Han, Hyo S, Buxton, Meredith, Clennell, Julia L, Asare, Smita M, Steeg, Katherine, Wilson, Amy, Singhrao, Ruby, Matthews, Jeffrey B, Perlmutter, Jane, Fraser Symmans, W, Hylton, Nola M, DeMichele, Angela M, Yee, Douglas, Van't Veer, Laura J, Berry, Donald A, Esserman, Laura J

Get full text

The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions by Ivanova, Anastasia, Israel, Elliot, Denlinger, Loren C., Phipatanakul, Wanda, Bacharier, Leonard B., Castro, Mario, Gaston, Benjamin, Khatri, Sumita, Kirwan, John P., Marquis, M. Alison, Moy, James N., Ortega, Victor E., Peters, Michael C., Ross, Kristie, Wenzel, Sally E., Zeki, Amir A., Noel, Patricia, Billheimer, Dean, Daines, Cori, Deaton, Isaac, Field, Paige, Hastie, Annette T., Hmieleski, Bob, Peters, Stephen P., Pippins, Anna, Schunk, Ronald, Banzon, Tina M., Bartnikas, Lisa M., Crestani, Elena, Day-Lewis, Megan, Esty, Brittany, Fandozzi, Eva, Fernandez, Jesse, Imanirad, Donya S., Louisias, Margee, O’Neill, Allison, Sheehan, William, Socolovsky, Carmela, Treffeisen, Else, Trippa, Lorenzo, Garcia, Vanessa, Jackson, Carly, Kalhan, Ravi, Li, Grace, Rosenberg, Sharon R., Sheng, Jianrong, Bitzan, Jennifer, Cruse, Margaret Hope, Estrom, Jean, Grant, Nicole, Manka, Laurie A., Pruitt, Diana M., Thomas, Kisori, Valente, Karissa, Brownell, Joshua, DeLisa, Julie, Fichtinger, Paul S., Goswamy, Vinay, Grogan, Jenelle, Hasse, Wendy, Mathur, Sameer K., Norwick, Lourdes M., Nyenhuis, Sharmilee M., Pappalardo, Andrea A., Rosenberg, Daniel L., Wollet, Lori, France, Lisa, Gluvna, Adam, Hyser, Elise, Krupp, Nadia L., Matuska, Brittany, Roesch, Erica A., Sanders, Don B., Teague, W. Gerald, Camiolo, Matt, Demas, Jessa, Elvin, Courtney, Lane, Lisa, Zhang, Michael, Brickner, Howard, Celso, Janelle, Du, Ashley, Nazir, Yusife, Ryu, Julie, Haczku, Angela, Harper, Richart W., Heromin, Raymond, Kuhn, Brooks T., McCourt, Paula, Singapuri, Amisha, Boomer, Jonathan S., Curtis, Vanessa, Thompson, Brynne, Britt, Ashley, Bryan, Hope, Jiang, Yue, Kosorok, Michael R., Meekins, Kelsey, Mollenhauer, Jeanette K., Ritz, Cheyanne

Get full text

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer by DeMichele, Angela, Yee, Douglas, Berry, Donald A, Albain, Kathy S, Benz, Christopher C, Boughey, Judy, Buxton, Meredith, Chia, Stephen K, Chien, Amy J, Chui, Stephen Y, Clark, Amy, Edmiston, Kirsten, Elias, Anthony D, Forero-Torres, Andres, Haddad, Tufia C, Haley, Barbara, Haluska, Paul, Hylton, Nola M, Isaacs, Claudine, Kaplan, Henry, Korde, Larissa, Leyland-Jones, Brian, Liu, Minetta C, Melisko, Michelle, Minton, Susan E, Moulder, Stacy L, Nanda, Rita, Olopade, Olufunmilayo I, Paoloni, Melissa, Park, John W, Parker, Barbara A, Perlmutter, Jane, Petricoin, Emanuel F, Rugo, Hope, Symmans, Fraser, Tripathy, Debasish, van't Veer, Laura J, Viscusi, Rebecca K, Wallace, Anne, Wolf, Denise, Yau, Christina, Esserman, Laura J

Get full text

Abstract PD8-07: Evaluation of Tucatinib + (Paclitaxel + Pertuzumab + Trastuzumab) followed by AC in high-risk HER2 positive (HER2+) stage II/III breast cancer: Results from the I-... by Potter, David A, Roesch, Erin, Yau, Christina, Lu, Ruixiao, Wolf, Denise, Samson, Susan, Stafford, Debra, Albain, Kathy S, Isaacs, Claudine, Trivedi, Meghana, Yee, Douglas, Boughey, Judy, Thomas, Alexandra, Chien, A. Jo, Hylton, Nola, Li, Wen, DeMichele, Angela, Perlmutter, Jane, Symmans, W. Fraser, Hershman, Dawn L, Melisko, Michelle, van 't Veer, Laura J, Wilson, Amy, Asare, Smita M, Berry, Donald A, Schwab, Richard, Rugo, Hope S, Esserman, Laura J

Get full text

Abstract PS4-08: Biomarker analysis of paclitaxel, ganitumab, and metformin (PGM) therapy in the I-SPY2 neoadjuvant clinical trial by Yee, Douglas, Haluska, Paul, Wolf, Denise M, Yau, Christina, Wilson, Amy, DeMichele, Angela, Isaacs, Claudine, Perlmutter, Jane, Venticinque, Joan, Rugo, Hope S, Schwab, Richard, Hylton, Nola M, Symmans, W Fraser, Melisko, Michelle E, Helsten, Teresa L, van't Veer, Laura J, Berry, Donald A, Esserman, Laura J

Get full text

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer by Yee, Douglas, Isaacs, Claudine, Wolf, Denise M., Yau, Christina, Haluska, Paul, Giridhar, Karthik V., Forero-Torres, Andres, Jo Chien, A., Wallace, Anne M., Pusztai, Lajos, Albain, Kathy S., Ellis, Erin D., Beckwith, Heather, Haley, Barbara B., Elias, Anthony D., Boughey, Judy C., Kemmer, Kathleen, Yung, Rachel L., Pohlmann, Paula R., Tripathy, Debu, Clark, Amy S., Han, Hyo S., Nanda, Rita, Khan, Qamar J., Edmiston, Kristen K., Petricoin, Emanuel F., Stringer-Reasor, Erica, Falkson, Carla I., Majure, Melanie, Mukhtar, Rita A., Helsten, Teresa L., Moulder, Stacy L., Robinson, Patricia A., Wulfkuhle, Julia D., Brown-Swigart, Lamorna, Buxton, Meredith, Clennell, Julia L., Paoloni, Melissa, Sanil, Ashish, Berry, Scott, Asare, Smita M., Wilson, Amy, Hirst, Gillian L., Singhrao, Ruby, Asare, Adam L., Matthews, Jeffrey B., Hylton, Nola M., DeMichele, Angela, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S., Fraser Symmans, W., van‘t Veer, Laura J., Berry, Donald A., Esserman, Laura J.

Get full text

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer by Lang, Julie E., Forero-Torres, Andres, Yee, Douglas, Yau, Christina, Wolf, Denise, Park, John, Parker, Barbara A., Chien, A. Jo, Wallace, Anne M., Murthy, Rashmi, Albain, Kathy S., Ellis, Erin D., Beckwith, Heather, Haley, Barbara B., Elias, Anthony D., Boughey, Judy C., Yung, Rachel L., Isaacs, Claudine, Clark, Amy S., Han, Hyo S., Nanda, Rita, Khan, Qamar J., Edmiston, Kristen K., Stringer-Reasor, Erica, Price, Elissa, Joe, Bonnie, Liu, Minetta C., Brown-Swigart, Lamorna, Petricoin, Emanuel F., Wulfkuhle, Julia D., Buxton, Meredith, Clennell, Julia L., Sanil, Ashish, Berry, Scott, Asare, Smita M., Wilson, Amy, Hirst, Gillian L., Singhrao, Ruby, Asare, Adam L., Matthews, Jeffrey B., Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S., Symmans, W. Fraser, van ‘t Veer, Laura J., Hylton, Nola M., DeMichele, Angela M., Berry, Donald A., Esserman, Laura J.

Get full text

Abstract B019: Clinical and molecular correlates of circulating tumor DNA (ctDNA) dynamics in breast tumors resistant to neoadjuvant therapy (NAT) by Magbanua, Mark Jesus M., Wolf, Denise M., Rivera-Hinojosa, Samuel, Ahmed, Ziad, Manon, Nayelis A., Sayaman, Rosalyn, Tin, Antony, Kalashnikova, Ekaterina, Swigart, Lamorna Brown, Hirst, Gillian L., Yau, Christina, Li, Wen, Isaacs, Claudine, Shatsky, Rebecca A., Delson, Amy L., Palsuledesai, Charuta C., Rodriguez, Angel, Liu, Minetta C., Pohlmann, Paula R., Esserman, Laura J., Rugo, Hope S., DeMichele, Angela, Veer, Laura van 't

Get full text

Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoa... by Helsten, Teresa L, Lo, Shelly S, Yau, Christina, Kalinsky, Kevin, Elias, Anthony D, Wallace, Anne M, Chien, A. Jo, Lu, Janice, Lang, Julie E, Albain, Kathy S, Stringer-Reasor, Erica, Clark, Amy S, Boughey, Judy C, Ellis, Erin D, Yee, Douglas, DeMichele, Angela, Isaacs, Claudine, Perlmutter, Jane, Rugo, Hope S, Schwab, Richard, Hylton, Nola M., Symmans, W. Fraser, Melisko, Michelle E, van't Veer, Laura J, Wilson, Amy, Singhrao, Ruby, Asare, Smita M, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Get full text

Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial by Gallagher, Rosa I, Wulfkuhle, Julia, Wolf, Denise M, Brown-Swigart, Lamorna, Yau, Christina, O'Grady, Nicholas, Basu, Amrita, Lu, Ruixiao, Campbell, Michael J, Magbanua, Mark J, Coppé, Jean-Philippe, Asare, Smita M, Sit, Laura, Matthews, Jeffrey B, Perlmutter, Jane, Hylton, Nola, Liu, Minetta C, Symmans, W Fraser, Rugo, Hope S, Isaacs, Claudine, DeMichele, Angela M, Yee, Douglas, Pohlmann, Paula R, Hirst, Gillian L, Esserman, Laura J, van 't Veer, Laura J, Petricoin, Emanuel F

Get full text